Streetbeat News

Price Targets

DAWN

Needham analyst Ami Fadia has maintained a Buy rating on Day One Biopharmaceutical (NASDAQ:DAWN) and raised the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:43 am

ZETA

Needham analyst Ryan MacDonald has reiterated a Buy rating on Zeta Global Holdings (NYSE:ZETA) and maintained a price target of $36.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 9:36 am

NMIH

Analysts have shown a positive trend in their recommendations for NMI Holdings (NASDAQ:NMIH) over the past quarter, with several raising their price targets. The average 12-month price target has increased by 12.74% to $44.25. NMI Holdings has demonstrated strong financial performance, with impressive revenue growth, net margin, and effective debt management.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 9:01 pm

PFSI

Analysts have mixed views on PennyMac Financial Services (NYSE:PFSI) with recent ratings showing a trend towards bullishness. The average 12-month price target has increased to $116.8, with a high of $125.00. Analysts have raised their ratings and price targets, reflecting positive sentiment.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 9:00 pm

NET

Analysts have varied opinions on Cloudflare (NYSE:NET), with recent ratings showing a mix of bullish and bearish sentiments. The average 12-month price target is $88.3, with a high of $135 and a low of $57. Recent analyst actions include rating adjustments and price target changes, reflecting their views on Cloudflare's market position and financial performance.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 9:00 pm

MDT

Medtronic (NYSE:MDT) has been analyzed by 15 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $93.33, with a high of $106.00 and a low of $85.00. Recent analyst actions include several rating raises and price target adjustments, reflecting evolving market conditions and company performance. Medtronic's financials show a 2.77% revenue growth, a net margin of 13.16%, but challenges in ROE and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 9:00 pm

TWLO

Twilio (NYSE:TWLO) has been analyzed by 8 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $78.25, with a high of $110.00 and a low of $65.00, reflecting a 3.64% increase from the previous target. Analysts have adjusted their ratings and price targets in response to market dynamics, with some raising and others lowering their expectations. Twilio's financial performance shows revenue growth, though below industry averages, and strong profitability metrics.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 9:00 pm

III

Barrington Research has reiterated its 'Outperform' rating for Information Services Group (NASDAQ:III) with a maintained price target of $3.5.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 8:50 pm